TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor

FEBS Journal

Volumn 277, Issue 23, 2010, Pages 4888-4900

  Hashimoto, Tomio ^a   Kato, Minoru ^b   Shimomura, Takeshi ^b   Kitamura, Naomi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Activation of pro hepatocyte growth factor; Hepatocyte growth factor activator inhibitor type 1 (HAI 1); Kunitz type inhibitor; TMPRSS13; Type II transmembrane serine protease (TTSP)

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TMPRSS13; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; MEMBRANE PROTEINS; MULTIPROTEIN COMPLEXES; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEINASE INHIBITORY PROTEINS, SECRETORY; RECOMBINANT PROTEINS; RNA, MESSENGER; SERINE ENDOPEPTIDASES;

EID: 78449285992     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07894.x     Document Type: Article

References (35)

1. Szabo R, Wu Q, Dickson RB, Netzel-Arnett S, Antalis TM & Bugge TH (2003) Type II transmembrane serine proteases. Thromb Haemost 90, 185-193.
2. Bugge TH, Antalis TM & Wu Q (2009) Type II transmembrane serine proteases. J Biol Chem 284, 23177-23181.
3. Choi SY, Bertram S, Glowacka I, Park YW & Pohlmann S (2009) Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med 15, 303-312.
4. Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, Kagaya S, Qin L, Takata H, Miyazawa K et al. (1997) Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 272, 6370-6376.
5. Lin C-Y, Anders J, Johnson M & Dickson RB (1999) Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274, 18237-18242.
6. Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, Fukushima T, Miyata S, Uchiyama S, Uchinokura S, Shimomura T et al. (2005) Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 25, 5687-5698.
7. Fan B, Brennan J, Grant D, Peale F, Rangell L & Kirchhofer D (2007) Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Dev Biol 303, 222-230.
8. Szabo R, Molinolo A, List K & Bugge TH (2007) Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 26, 1546-1556.
9. Kirchhofer D, Peek M, Lipari T, Billeci K, Fan B & Moran P (2005) Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett 579, 1945-1950.
10. Herter S, Piper DE, Aaron W, Gabriele T, Cuter G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N et al. (2005) Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 390, 125-136.
11. Kim DR, Sharmin S, Inoue M & Kido H (2001) Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung. Biochim Biophys Acta 1518, 204-209.
12. Kido H & Okumura Y (2008) MSPL/TMPRSS13. Front Biosci 13, 754-758.
13. Okumura Y, Takahashi E, Yano M, Ohuchi M, Daidoji T, Nakaya T, Bottcher E, Garten W, Klenk HD & Kido H (2010) Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol 84, 5089-5096.
14. Shimomura T, Denda K, Kawaguchi T, Matsumoto K, Miyazawa K & Kitamura N (1999) Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J Biochem 126, 821-828.
15. Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K & Kitamura N (1997) Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 272, 27558-27564.
16. Marlor CM, Delaria KA, Davis G, Muller DK, Greve JM & Tamburini PP (1997) Identification and cloning of human placenta bikunin, a novel serine protease inhibitor containing two Kunitz domains. J Biol Chem 272, 12202-12208.
17. Szabo R, Hobson JP, List K, Molinolo A, Lin C-Y & Bugge TH (2008) Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J Biol Chem 283, 29495-29504.
18. Lee SL, Dickson RB & Lin CY (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275, 36720-36725.
19. Kondo A, Hirayama N, Sugito Y, Shono M, Tanaka T & Kitamura N (2008) Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation. J Biol Chem 283, 1428-1436.
20. Tsukada Y, Miyazawa K & Kitamura N (2001) High-intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 276, 40968-40976.
21. Hobson JP, Netzel-Arnett S, Szabo R, Rehault SM, Church FC, Strickland DK, Lawrence DA, Antalis TM & Bugge TH (2004) Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. J Biol Chem 279, 46981-46994.
22. Denda K, Shimomura T, Kawaguchi T, Miyazawa K & Kitamura N (2002) Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem 277, 14053-14059.
23. Kojima K, Tsuzuki S, Fushiki T & Inouye K (2008) Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. J Biol Chem 283, 2478-2487.
24. Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y & Kitamura N (1995) Activation of hepatocyte growth factor by two homologous proteases, blood coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 229, 257-261.
25. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K et al. (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163, 967-973.
26. Brinkmann V, Foroutan H, Sachs H, Weidner KM & Birchmeier W (1995) Hepatocyte growth factor/scatter factor induces a variety of tissue specific morphogenic programs in epithelial cells. J Cell Biol 131, 1573-1586.
27. Matsumoto K & Nakamura T (1996) Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119, 591-600.
28. Miyazawa K, Shimomura T, Naka D & Kitamura N (1994) Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 269, 8966-8970.
29. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T & Kitamura N (1992) Activation of hepatocyte growth factor by proteolytic conversion of a single-chain form to a heterodimer. J Biol Chem 267, 20114-20119.
30. Gak E, Taylor WG, Chan AM-L & Rubin JS (1992) Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett 311, 17-21.
31. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y & Kitamura N (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor - structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 268, 10024-10028.
32. Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T et al. (2004) Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127, 1423-1435.
33. Peek M, Moran P, Mendoza N, Wichramasinghe D & Kichhofer D (2002) Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa. J Biol Chem 277, 47804-47809.
34. Shimomura T, Ochiai M, Kondo J & Morimoto Y (1992) A novel protease obtained from FBS-containing culture supernatant, that processes single-chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8, 219-229.
35. Kirchhofer D, Peek M, Li W, Stamos J, Eigenbrot C, Kadkhodayan S, Elliott JM, Corpuz T, Lazarus RA & Moran P (2003) Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem 278, 36341-36349.